Skip to content

To study the effect of Panchakarma Essential (Katibasti) in the management of lower back pain.

To study the safety and efficacy of Panchakarma Essential (Katibasti) in the management of lower back pain. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058165
Enrollment
30
Registered
2023-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M545- Low back pain

Interventions

Intervention1: Sahacharadi oil: To be massaged on affected area for 11 days Control Intervention1: Standard Sahacharadi oil: To be massaged on affected area for 11 days

Sponsors

Mprex Healthcare Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female subjects 30-60 years of age (both inclusive)2.Subject has a confirmed diagnosis of lower back pain for a minimum of 3 months.3.Subject having Oswestry low back pain disability score below 80%.4.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures

Exclusion criteria

Exclusion criteria: 1.Female patients having pregnancy or post-delivery period. 2.Subjects having lower back pain due to osteoporosis, especially having excessive distention of the abdomen due to obesity, and bone cancer. 3. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
1. To study the efficacy of Panchakarma Essential in the management of lower back pain. 2. To assess the reduction in painTimepoint: from screening to end of the study

Secondary

MeasureTime frame
1. To measure the Roland-Morris Low Back Pain & Disability Questionnaire (RMQ) 2. To assess the improvement in the Quality of life of a patient.Timepoint: at screening & end of the study

Countries

India

Contacts

Public ContactDr Vaishnavi Patil

Mprex Healthcare Pvt. Ltd.

vaishnavi@mprex.in9834585994

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026